Published in Medical Patent Law Weekly, August 15th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Caliper Life Sciences.
Report 1: Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of instruments and services for pre-clinical drug research, today announced its first quarter financial results for 2007. First quarter revenues were $28.4 million, an increase of 28% from $22.3 million in the same period in 2006. Net loss for the quarter was $9.6 million ($0.20 per share) compared to a net loss of $4.4 million ($0.13 per share) in the same quarter of 2006. Caliper...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.